Serum B12 at 7 days post-injection is equivalent (Andrs et al., 2018)
Reviewed on Shavon 2 ratings|1 review I had a good experience would recommend
Aye S, Johansson G, Hock C et al (2025) Point of view: challenges in implementation of new immunotherapies for Alzheimers disease
BPC-157 + TB-500 (Thymosin Beta-4) Why it works : BPC-157 excels at localized healing (joints, tendons, muscle), while TB-500 supports systemic recovery by increasing actin production and improving cellular migration
However, so far, no significant adverse effects have been consistently reported
administered BPC 157 (10mcg/kg or 10 ng/kg) orally, in drinking water (12 ml/rat/day) or intraperitoneally (once daily, first application 30 min following surgery to test its effects on short bowel syndrome in rats, observing the effectiveness of both forms of administration [24]